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Following publication of the original article \[[@CR1]\], it has been brought to our attention that an incorrect Sequenom MassArray trace and an incorrect nomenclature were used to represent the PIK3CA p.E545A mutation in Fig. 2b. The correct Fig. [2](#Fig2){ref-type="fig"}b is shown in this erratum. The authors apologize for the confusion.Fig. 2**a** Mutational profiling of the 15 cases profiled through a hotspot multigene mutational custom panel, including 164 hotspot regions of *AKT1, APC, BRAF, CTNNB1, KIT, KRAS, NRAS, PDGFRA, PIK3CA, PTEN* and *TP53* genes. In red are the samples showing a different mutational landscape in comparison to the other matched samples (scale bars = 100 µm). **b** Representative Sequenom MassArray output profiles for *KRAS* c.436G\> A (p.A146T), *PIK3CA* c.1634A\>C (p.E545A), *BRAF* c1799T\>A (p.V600E) and *NRAS* c.35G\>A (p.G12D) mutations. On the right the correspondent Sanger chromatogram
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